CD8A and neoplasm: Moreover, EMT-TFs have been shown to be associated with reduced expression of major histocompatibility complex (MHC) Class I [141,142], which plays a pivotal role in the presentation of tumor antigens on the tumor cell surface for recognition by CD8+ T cells and activation of cytotoxic T cell responses [143].